Related Experiment Video
Updated: Jun 18, 2026

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer
Published on: April 13, 2015
Deregulated GSK3{beta} sustains gastrointestinal cancer cells survival by modulating human telomerase reverse
Wei Mai1, Kazuyuki Kawakami, Abbas Shakoori
1Division of Translational and Clinical Oncology, Cancer Research Institute, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan.
Purpose:
Glycogen synthase kinase-3beta (GSK3beta) regulates multiple cell signaling pathways and has been implicated in glucose intolerance, neurodegenerative disorders, and inflammation. We investigated the expression, activity, and putative pathologic role of GSK3beta in gastrointestinal, pancreatic, and liver cancers.
Experimental Design:
Colon, stomach, pancreatic, and liver cancer cell lines; nonneoplastic HEK293 cells; and matched pairs of normal and tumor tissues of stomach and colon cancer patients were examined for GSK3beta expression and its phosphorylation at serine 9 (inactive form) and tyrosine 216 (active form) by Western immunoblotting and for GSK3beta activity by in vitro kinase assay. The effects of small-molecule GSK3beta inhibitors and of RNA interference on cell survival, proliferation, and apoptosis were examined in vitro and on human colon cancer cell xenografts in athymic mice. The effects of GSK3beta inhibition on human telomerase reverse transcriptase (hTERT) expression and telomerase activity were compared between colon cancer and HEK293 cells.
Results:
Cancer cell lines and most cancer tissues showed increased GSK3beta expression and increased tyrosine 216 phosphorylation and activity but decreased serine 9 phosphorylation compared with HEK293 cells and nonneoplastic tissues. Inhibition of GSK3beta resulted in attenuated cell survival and proliferation and increased apoptosis in most cancer cell lines and in HT-29 xenografts in rodents but not in HEK293 cells. GSK3beta inhibition in colon cancer cells was associated with decreased hTERT expression and telomerase activity.
Conclusion:
The results indicate that deregulated GSK3beta sustains gastrointestinal cancer cells survival through modulation of hTERT and telomerase.
Insights
Dysregulated Glycogen synthase kinase-3beta (GSK3beta) promotes gastrointestinal cancer survival by affecting human telomerase reverse transcriptase (hTERT) and telomerase activity. Inhibiting GSK3beta reduces cancer cell proliferation and increases apoptosis.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Glycogen synthase kinase-3beta (GSK3beta) is a key regulator in cellular signaling pathways.
- GSK3beta dysregulation is linked to various diseases including cancer, inflammation, and metabolic disorders.
Purpose of the Study:
- To investigate the expression, activity, and role of GSK3beta in gastrointestinal, pancreatic, and liver cancers.
- To determine if GSK3beta inhibition impacts cancer cell survival, proliferation, and apoptosis.
Main Methods:
- Examined GSK3beta expression and activity in cancer cell lines and patient tissues using Western immunoblotting and kinase assays.
- Assessed the effects of GSK3beta inhibitors and RNA interference on cancer cells in vitro and in xenografts.
- Compared the impact of GSK3beta inhibition on human telomerase reverse transcriptase (hTERT) and telomerase activity in cancer cells versus normal cells.
Main Results:
- Elevated GSK3beta expression, activity, and tyrosine 216 phosphorylation were observed in cancer cells and tissues.
- GSK3beta inhibition reduced cancer cell survival and proliferation while increasing apoptosis in most cancer models.
- Inhibition of GSK3beta in colon cancer cells led to decreased hTERT expression and telomerase activity.
Conclusions:
- Aberrant GSK3beta activity is crucial for sustaining gastrointestinal cancer cell survival.
- GSK3beta modulates cancer cell fate through the regulation of hTERT and telomerase.
Related Concept Videos
Replicative Cell Senescence
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Negative Regulator Molecules
Mitogens and the Cell Cycle